Literature DB >> 1331522

A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter.

G L Bream1, P Vaillancourt, M R Botchan.   

Abstract

The bovine papillomavirus upstream regulatory region represents a common element in the regulation of transcription from the five early viral promoters. We have determined the sequences required for transcription from the viral P1 promoter, which is located at the 5' end of the upstream regulatory region. In vitro transcription from P1 requires a 123-bp fragment (nucleotides 7153 to 7275; -33 to +90) consisting of an upstream TATA-like sequence as well as an unidentified protein which binds to sequences immediately downstream of the initiation site. In vivo, this promoter requires additional downstream sequences (to position +160; nucleotide 7345) for maximal activity but does not require any additional DNA sequence upstream of a putative TATA box. Four regions within the downstream sequence from +9 to +160 are protected from DNase I digestion by proteins present in a HeLa cell extract. The presence of these sites correlates with the level of P1 activity. A constitutive enhancer maps to this same region, and mutations in this enhancer have been shown to affect downstream promoters. Deletion analysis indicates that the same sequences are required by both the P1 promoter and the constitutive enhancer, suggesting that the same proteins function in both activities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331522      PMCID: PMC240436     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Modularity in promoters and enhancers.

Authors:  W S Dynan
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.

Authors:  M T Chin; T R Broker; L T Chow
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region.

Authors:  B A Spalholz; P F Lambert; C L Yee; P M Howley
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

4.  Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18.

Authors:  A Garcia-Carranca; F Thierry; M Yaniv
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix.

Authors:  M M Pater; A Pater
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

7.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator.

Authors:  P F Lambert; B A Spalholz; P M Howley
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

8.  Transient replication of bovine papilloma virus type 1 plasmids: cis and trans requirements.

Authors:  M Lusky; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene.

Authors:  T H Haugen; T P Cripe; G D Ginder; M Karin; L P Turek
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

10.  The bovine papillomavirus P2443 promoter is E2 trans-responsive: evidence for E2 autoregulation.

Authors:  P L Hermonat; B A Spalholz; P M Howley
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  1 in total

1.  Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Authors:  Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.